InvestorsHub Logo
Followers 21
Posts 1095
Boards Moderated 0
Alias Born 01/28/2014

Re: Abundance88 post# 34364

Thursday, 01/25/2024 2:45:25 PM

Thursday, January 25, 2024 2:45:25 PM

Post# of 34588
Completely agree that Bumka is focusing on Biotech and not CPG's. But the thing is that CPG was a way to fund biotech's trails and not dilute the shit out of shareholders. I have been holding bag and clearly frustrated with Bumka and find it hard to trust his narratives.
For me as a layman if DHT which seems to be "The thing" and the best one as per results published so far, why are biotech's not investing at this low mcap. Its a chump change for Biotech or Tobacco companies to partner at this stage with Lexx instead of waiting out.

This shareholder letter is also visible to other's from Big Pharma / Big Tobacco, how come they are not jumping up and down on their seats looking al the human trials of Nicotine or GLP-1 or CBD or Antiviral or any of those. Cause I believe, we have increase the bioavailability in each of the cases and non of the results from any of the previously taken trials had anything to suggest anything negative abt it.

There are too many +ve streams , but none of them is materializing , so it is very frustrating. This stock should have been $30-40 and mcap of 300-400 mil when the revenue potential is in few billions at the least. Hard to explain the market or rather Market know's it that we long terms don't
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LEXX News